Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Pneumococcal Vaccines market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Pneumococcal Vaccines market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Pneumococcal Vaccines market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Pneumococcal Vaccines products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Pneumococcal Vaccines products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Pneumococcal Vaccines market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Pneumococcal Vaccines development has been the leading industry trend of Pneumococcal Vaccines market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Pneumococcal Vaccines Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
PPSV 23,PCV 7/13,PCV 10, Other |
| By Application Outlook |
For Infants,For Children (2-10),For Person (10-64),For The Old (?65) |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Pfizer,Sanofi,GSK,Merck,Eli Lilly,AstraZeneca,Abera,S K Chemicals,Beijing Minhai Biotechnology,Baxter,Biken,Celgene Corporation,Panacea Biotec,Serum Institute of India,Genentech,Genocea Biosciences,ImmunoBiology,Lupin,Nuron Biotech,Biogen,Valneva Austria,Sinovac |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Pfizer
- Sanofi
- GSK
- Merck
- Eli Lilly
- AstraZeneca
- Abera
- S K Chemicals
- Beijing Minhai Biotechnology
- Baxter
- Biken
- Celgene Corporation
- Panacea Biotec
- Serum Institute of India
- Genentech
- Genocea Biosciences
- ImmunoBiology
- Lupin
- Nuron Biotech
- Biogen
- Valneva Austria
- Sinovac
Pneumococcal Vaccines Market, By Type
- PPSV 23
- PCV 7/13
- PCV 10
- Other
Pneumococcal Vaccines Market, By Application
- For Infants
- For Children (2-10)
- For Person (10-64)
- For The Old (?65)
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
1 Study Coverage
1.1 Pneumococcal Vaccines Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Pneumococcal Vaccines Market Size Growth Rate by Product
1.4.2 PPSV 23
1.4.3 PCV 7/13
1.4.4 PCV 10
1.5 Market by End User
1.5.1 Global Pneumococcal Vaccines Market Size Growth Rate by End User
1.5.2 For Infants
1.5.3 For Children (2-10)
1.5.4 For Person (10-64)
1.5.5 For The Old (?65)
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Pneumococcal Vaccines Market Size
2.1.1 Global Pneumococcal Vaccines Revenue 2014-2027
2.1.2 Global Pneumococcal Vaccines Sales 2014-2027
2.2 Pneumococcal Vaccines Growth Rate by Regions
2.2.1 Global Pneumococcal Vaccines Sales by Regions
2.2.2 Global Pneumococcal Vaccines Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Pneumococcal Vaccines Sales by Manufacturers
3.1.1 Pneumococcal Vaccines Sales by Manufacturers
3.1.2 Pneumococcal Vaccines Sales Market Share by Manufacturers
3.1.3 Global Pneumococcal Vaccines Market Concentration Ratio (CR5 and HHI)
3.2 Pneumococcal Vaccines Revenue by Manufacturers
3.2.1 Pneumococcal Vaccines Revenue by Manufacturers (2014-2019)
3.2.2 Pneumococcal Vaccines Revenue Share by Manufacturers (2014-2019)
3.3 Pneumococcal Vaccines Price by Manufacturers
3.4 Pneumococcal Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Pneumococcal Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pneumococcal Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Pneumococcal Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Pneumococcal Vaccines Sales by Product
4.2 Global Pneumococcal Vaccines Revenue by Product
4.3 Pneumococcal Vaccines Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Pneumococcal Vaccines Breakdown Data by End User
6 North America
6.1 North America Pneumococcal Vaccines by Countries
6.1.1 North America Pneumococcal Vaccines Sales by Countries
6.1.2 North America Pneumococcal Vaccines Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Pneumococcal Vaccines by Product
6.3 North America Pneumococcal Vaccines by End User
7 Europe
7.1 Europe Pneumococcal Vaccines by Countries
7.1.1 Europe Pneumococcal Vaccines Sales by Countries
7.1.2 Europe Pneumococcal Vaccines Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pneumococcal Vaccines by Product
7.3 Europe Pneumococcal Vaccines by End User
8 Asia Pacific
8.1 Asia Pacific Pneumococcal Vaccines by Countries
8.1.1 Asia Pacific Pneumococcal Vaccines Sales by Countries
8.1.2 Asia Pacific Pneumococcal Vaccines Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Pneumococcal Vaccines by Product
8.3 Asia Pacific Pneumococcal Vaccines by End User
9 Central & South America
9.1 Central & South America Pneumococcal Vaccines by Countries
9.1.1 Central & South America Pneumococcal Vaccines Sales by Countries
9.1.2 Central & South America Pneumococcal Vaccines Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Pneumococcal Vaccines by Product
9.3 Central & South America Pneumococcal Vaccines by End User
10 Middle East and Africa
10.1 Middle East and Africa Pneumococcal Vaccines by Countries
10.1.1 Middle East and Africa Pneumococcal Vaccines Sales by Countries
10.1.2 Middle East and Africa Pneumococcal Vaccines Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Pneumococcal Vaccines by Product
10.3 Middle East and Africa Pneumococcal Vaccines by End User
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Business Overview
11.1.3 Pfizer Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Pfizer Pneumococcal Vaccines Products Offered
11.1.5 Pfizer Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Company Business Overview
11.2.3 Sanofi Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Sanofi Pneumococcal Vaccines Products Offered
11.2.5 Sanofi Recent Development
11.3 GSK
11.3.1 GSK Company Details
11.3.2 Company Business Overview
11.3.3 GSK Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.3.4 GSK Pneumococcal Vaccines Products Offered
11.3.5 GSK Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Company Business Overview
11.4.3 Merck Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Merck Pneumococcal Vaccines Products Offered
11.4.5 Merck Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Details
11.5.2 Company Business Overview
11.5.3 Eli Lilly Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Eli Lilly Pneumococcal Vaccines Products Offered
11.5.5 Eli Lilly Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 Company Business Overview
11.6.3 AstraZeneca Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.6.4 AstraZeneca Pneumococcal Vaccines Products Offered
11.6.5 AstraZeneca Recent Development
11.7 Abera
11.7.1 Abera Company Details
11.7.2 Company Business Overview
11.7.3 Abera Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Abera Pneumococcal Vaccines Products Offered
11.7.5 Abera Recent Development
11.8 S K Chemicals
11.8.1 S K Chemicals Company Details
11.8.2 Company Business Overview
11.8.3 S K Chemicals Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.8.4 S K Chemicals Pneumococcal Vaccines Products Offered
11.8.5 S K Chemicals Recent Development
11.9 Beijing Minhai Biotechnology
11.9.1 Beijing Minhai Biotechnology Company Details
11.9.2 Company Business Overview
11.9.3 Beijing Minhai Biotechnology Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Beijing Minhai Biotechnology Pneumococcal Vaccines Products Offered
11.9.5 Beijing Minhai Biotechnology Recent Development
11.10 Baxter
11.10.1 Baxter Company Details
11.10.2 Company Business Overview
11.10.3 Baxter Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Baxter Pneumococcal Vaccines Products Offered
11.10.5 Baxter Recent Development
11.11 Biken
11.12 Celgene Corporation
11.13 Panacea Biotec
11.14 Serum Institute of India
11.15 Genentech
11.16 Genocea Biosciences
11.17 ImmunoBiology
11.18 Lupin
11.19 Nuron Biotech
11.20 Biogen
11.21 Valneva Austria
11.22 Sinovac
12 Future Forecast
12.1 Pneumococcal Vaccines Market Forecast by Regions
12.1.1 Global Pneumococcal Vaccines Sales Forecast by Regions 2020-2027
12.1.2 Global Pneumococcal Vaccines Revenue Forecast by Regions 2020-2027
12.2 Pneumococcal Vaccines Market Forecast by Product
12.2.1 Global Pneumococcal Vaccines Sales Forecast by Product 2020-2027
12.2.2 Global Pneumococcal Vaccines Revenue Forecast by Product 2020-2027
12.3 Pneumococcal Vaccines Market Forecast by End User
12.4 North America Pneumococcal Vaccines Forecast
12.5 Europe Pneumococcal Vaccines Forecast
12.6 Asia Pacific Pneumococcal Vaccines Forecast
12.7 Central & South America Pneumococcal Vaccines Forecast
12.8 Middle East and Africa Pneumococcal Vaccines Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pneumococcal Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
